Primary Site >> Colorectal Cancer

Gene >> RGS5

Journal: Pharmacogenomics J. 2015 Feb;15(1):69-76.
Title: Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer.
Author: Volz, N B|Stintzing, S|Zhang, W|Yang, D|Ning, Y|Wakatsuki, T|El-Khoueiry, R E|Li, J E|Kardosh, A|Loupakis, F|Cremolini, C|Falcone, A|Scherer, S J|Lenz, H-J
PMID: 25069475
Journal: Drug Metab Pers Ther. 2016 Jun 1;31(2):83-90.
Title: Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen.
Author: Gonzalez-Vacarezza, Nicolas|Alonso, Isabel|Arroyo, Gustavo|Martinez, Jorge|De Andres, Fernando|LLerena, Adrian|Estevez-Carrizo, Francisco
PMID: 26974145